首页> 外文OA文献 >Lactobacillus bulgaricus Proteinase Expressed in Lactococcus lactis Is a Powerful Carrier for Cell Wall-Associated and Secreted Bovine β-Lactoglobulin Fusion Proteins
【2h】

Lactobacillus bulgaricus Proteinase Expressed in Lactococcus lactis Is a Powerful Carrier for Cell Wall-Associated and Secreted Bovine β-Lactoglobulin Fusion Proteins

机译:乳酸乳球菌中表达的保加利亚乳杆菌蛋白酶是细胞壁相关和分泌的牛β-乳球蛋白融合蛋白的有力载体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lactic acid bacteria have a good potential as agents for the delivery of heterologous proteins to the gastrointestinal mucosa and thus for the reequilibration of inappropriate immune responses to food antigens. Bovine β-lactoglobulin (BLG) is considered a major allergen in cow's milk allergy. We have designed recombinant Lactococcus lactis expressing either full-length BLG or BLG-derived octapeptide T6 (IDALNENK) as fusions with Lactobacillus bulgaricus extracellular proteinase (PrtB). In addition to constructs encoding full-length PrtB for the targeting of heterologous proteins to the cell surface, we generated vectors aiming at the release into the medium of truncated PrtB derivatives lacking 100 (PrtB∂, PrtB∂-BLG, and PrtB∂-T6) or 807 (PrtBΔ) C-terminal amino acids. Expression of recombinant products was confirmed using either anti-PrtB, anti-BLG, or anti-peptide T6 antiserum. All forms of the full-length and truncated recombinant products were efficiently translocated, irrespective of the presence of eucaryotic BLG sequences in the fusion proteins. L. lactis expressing PrtB∂-BLG yielded up to 170 μg per 109 CFU in the culture supernatant and 9 μg per 109 CFU at the bacterial cell surface within 14 h. Therefore, protein fusions relying on the use of PrtB gene products are adequate for concomitant cell surface display and secretion by recombinant L. lactis and thus may ensure maximal bioavailability of the eucaryotic antigen in the gut-associated lymphoid tissue.
机译:乳酸菌具有作为将异源蛋白递送至胃肠粘膜并因此重新平衡对食物抗原的不适当免疫应答的试剂的良好潜力。牛β-乳球蛋白(BLG)被认为是牛奶过敏的主要过敏原。我们设计了重组乳球菌,表达全长BLG或BLG衍生的八肽T6(IDALNENK)与保加利亚乳杆菌细胞外蛋白酶(PrtB)融合。除了编码全长PrtB以将异源蛋白靶向细胞表面的构建体外,我们还生成了旨在将缺少100的截短的PrtB衍生物释放到培养基中的载体(PrtB∂,PrtB∂-BLG和PrtB∂-T6 )或807(PrtBΔ)C端氨基酸。使用抗PrtB,抗BLG或抗肽T6抗血清可以证实重组产物的表达。无论融合蛋白中是否存在真核BLG序列,所有形式的全长和截短的重组产物均能有效转移。表达PrtB 1 -BLG的乳酸乳球菌在培养上清液中每109 CFU产生高达170μg,在细菌细胞表面上每109 CFU产生9μg。因此,依赖于使用PrtB基因产物的蛋白质融合体足以伴随重组乳酸乳球菌的细胞表面展示和分泌,因此可以确保真核抗原在肠道相关淋巴组织中的最大生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号